Financial Incentives to Improve Medication Adherence

Sponsor
Northwell Health (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04191876
Collaborator
(none)
25
1
1
28.9
0.9

Study Details

Study Description

Brief Summary

Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.

Condition or Disease Intervention/Treatment Phase
  • Other: Wellth - Financial Incentives
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Financial Incentives to Improve Medication Adherence: a Pilot Study
Actual Study Start Date :
Nov 1, 2019
Actual Primary Completion Date :
May 30, 2020
Anticipated Study Completion Date :
Mar 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active

This study has only one arm. All patients enrolled will take part in the experimental arm.

Other: Wellth - Financial Incentives
Patients who are willing to participate will be offered financial incentives for medication adherence through an app (Wellth) over 10 weeks.

Outcome Measures

Primary Outcome Measures

  1. Change in medication adherence rate [Between baseline and study completion (10 weeks)]

    Adherence rate will be measured as pills missed/pills prescribed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Psychiatric patients with suspected or confirmed poor oral medication adherence.

  2. Age 18-80 years old

  3. English speaking, since the app being used is only available in English

  4. Owning a Smartphone, since the app requires a Smartphone to work

  5. Willing and able to participate.

Exclusion Criteria:
  1. Acute anger to self or others as per investigator assessment

  2. Unwilling or unable to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Zucker Hillside Hospital Glen Oaks New York United States 11004

Sponsors and Collaborators

  • Northwell Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Northwell Health
ClinicalTrials.gov Identifier:
NCT04191876
Other Study ID Numbers:
  • 19-0739-ZHH
First Posted:
Dec 10, 2019
Last Update Posted:
Jul 9, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Northwell Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 9, 2021